Literature DB >> 12020474

Diseases of the neuromuscular junction.

John McConville1, Angela Vincent.   

Abstract

The neuromuscular junction is a prototype synapse and it is also the site of well-characterised autoimmune and hereditary disorders. In the presynaptic terminal, voltage-gated potassium channels and voltage-gated calcium channels are subtly altered in genetic disorders and mutations in the enzyme that synthesises acetylcholine have been demonstrated in a particular form of hereditary myasthenia syndrome. Recent advances have revealed agrin, muscle-specific kinase (MuSK) and rapsyn as important signalling elements in the development and maintainance of the molecular architecture of the postsynaptic membrane. This is proving relevant to seronegative myasthenia gravis, with the discovery of anti-MuSK antibodies, and to a type of congenital myasthenic syndrome, in which acetylcholine receptor deficiency is due to mutations in rapsyn.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020474     DOI: 10.1016/s1471-4892(02)00156-x

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  9 in total

1.  Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.

Authors:  Masatoshi Suzuki; Jacalyn McHugh; Craig Tork; Brandon Shelley; Antonio Hayes; Ilaria Bellantuono; Patrick Aebischer; Clive N Svendsen
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

2.  Casein kinase 2-dependent serine phosphorylation of MuSK regulates acetylcholine receptor aggregation at the neuromuscular junction.

Authors:  Tatiana Cheusova; Muhammad Amir Khan; Steffen Wolfgang Schubert; Anne-Claude Gavin; Thierry Buchou; Germaine Jacob; Heinrich Sticht; Jorge Allende; Brigitte Boldyreff; Hans Rudolf Brenner; Said Hashemolhosseini
Journal:  Genes Dev       Date:  2006-07-01       Impact factor: 11.361

3.  A human congenital myasthenia-causing mutation (epsilon L78P) of the muscle nicotinic acetylcholine receptor with unusual single channel properties.

Authors:  Christopher Shelley; David Colquhoun
Journal:  J Physiol       Date:  2005-02-24       Impact factor: 5.182

4.  Control of rapsyn stability by the CUL-3-containing E3 ligase complex.

Authors:  Seunghee Nam; Kyoengwoo Min; Hyejin Hwang; Hae-Ock Lee; Jung Hwa Lee; Jongbok Yoon; Hyunsook Lee; Sungsu Park; Junho Lee
Journal:  J Biol Chem       Date:  2009-01-20       Impact factor: 5.157

5.  Examination of transcript amounts and activity of protein kinase CK2 in muscle lysates of different types of human muscle pathologies.

Authors:  Dieter Heuss; Janine Klascinski; Steffen W Schubert; Tehmur Moriabadi; Hanns Lochmüller; Said Hashemolhosseini
Journal:  Mol Cell Biochem       Date:  2008-06-14       Impact factor: 3.396

6.  Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model.

Authors:  Gabriella Dobrowolny; Cristina Giacinti; Laura Pelosi; Carmine Nicoletti; Nadine Winn; Laura Barberi; Mario Molinaro; Nadia Rosenthal; Antonio Musarò
Journal:  J Cell Biol       Date:  2005-01-17       Impact factor: 10.539

Review 7.  Animal models of myasthenia gravis: utility and limitations.

Authors:  Renato Mantegazza; Chiara Cordiglieri; Alessandra Consonni; Fulvio Baggi
Journal:  Int J Gen Med       Date:  2016-03-04

8.  Biomarkers of sarcopenia in very old patients with hip fracture.

Authors:  Carmen Sánchez-Castellano; Sagrario Martín-Aragón; Paloma Bermejo-Bescós; Nieves Vaquero-Pinto; Carmen Miret-Corchado; Ana Merello de Miguel; Alfonso José Cruz-Jentoft
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-01-08       Impact factor: 12.910

Review 9.  Basal lamina changes in neurodegenerative disorders.

Authors:  Benjamin Nguyen; Gregory Bix; Yao Yao
Journal:  Mol Neurodegener       Date:  2021-12-07       Impact factor: 14.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.